The NHS access journey, should CagriSema receive approval, would then follow a separate NICE appraisal process the same pathway that Wegovy and Mounjaro have navigated
I dont recommend running BPC 157 indefinitely, not because theres data showing long-term harm but because we simply dont have long-term human safety data
Chemical peels using glycolic or lactic acid at professional concentrations accelerate pigmented cell turnover, laser treatments like Q-switched or IPL target melanin directly with high energy, dermal fillers restore volume correcting structural shadows peptides cannot address, and microneedling enhances peptide penetration while stimulating additional collagen production through controlled injury response
This is right when most people are still in the "nothing visible yet" phase, and they conclude it "doesn't work." Give it the full 8 to 12 weeks before deciding
Strengthening diagnostics, expanding access to care, and fostering cross-sector collaboration are essential for reducing the global burden
9 Richie JP Jr, et al